« Home « Kết quả tìm kiếm

Neoadjuvant chemotherapy


Tìm thấy 20+ kết quả cho từ khóa "Neoadjuvant chemotherapy"

The role of postmastectomy radiation in patients with ypN0 breast cancer after neoadjuvant chemotherapy: A metaanalysis

tailieu.vn

Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer. Role of postmastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancer. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer:. https://doi.org/10.1093/annonc/mdw046..

Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2)

tailieu.vn

Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2-IIA bulky cervical cancer. https://doi.org/10.3802/jgo . Response to neoadjuvant chemotherapy on locally advanced cervical cancer and long-term follow-up outcome. Neoadjuvant chemotherapy in cervical cancer: a new trend.

Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triplenegative breast cancer: A systematic review and meta-analysis

tailieu.vn

Neoadjuvant immune-checkpoint blockade in triple-negative breast Cancer: current evidence and litera- ture-based Meta-analysis of randomized trials. Immuno- therapy addition to neoadjuvant chemotherapy for early triple negative breast cancer: a systematic review and meta-analysis of randomized clinical trials. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.

Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy

tailieu.vn

CT and MRI to predict the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis. https://doi.org/10.1038/s . Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancer.

Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: A large, multicenter, observational study

tailieu.vn

The authors tried to evaluate chemotherapy response of very young patients with ER- positive BC by pathologic complete response (pCR) after neoadjuvant chemotherapy excluding the effect of endocrine treatment to the extent possible..

Triplet versus doublet neoadjuvant chemotherapy regimens for locally advanced gastric cancer: A propensity score matching analysis

tailieu.vn

Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-nạve patients with advanced gastric cancer. Kim GM, Jeung HC, Rha SY, Kim HS, Jung I, Nam BH, et al. A rand- omized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer. Satake H, Miki A, Kondo M, Kotake T, Okita Y, Hatachi Y, et al. Phase I study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (neo G-SOX PI).

Significance of the neutrophil-tolymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: A multicentre retrospective study

tailieu.vn

Significance of the neutrophil-to-. lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity. The purpose of this study was to investigate the significance of the neutrophil-to-lympho- cyte ratio (NLR) in predicting the response to NACT in extremity osteosarcoma.. Methods: Pathological complete response (pCR) was used to assess the efficacy of NACT.

Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5- fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC)

tailieu.vn

The pri- mary objective is to assess the efficacy of neoadjuvant NAPOX chemotherapy followed by R0/R1 resection in patients with hepatic oligometastatic adenocarcinoma of the pancreas. To this end, overall survival after R0/R1 resection (OS-res) for patients with R0/R1 resection after neoadjuvant chemotherapy will be used as the primary endpoint..

Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: The PRE-PREVENCYS trial

tailieu.vn

Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis. https://doi.org ju . https://doi.org/10.1016/S . https://doi.org . Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. https://doi.org/10.1016/j.. Bladder Cancer

Evaluating the effect of Neoadjuvant chemotherapy for esophageal Cancer using the RECIST system with shorter-axis measurements: A retrospective multicenter study

tailieu.vn

Each measurement was performed in the same horizontal slice and the same direction before and after neoadjuvant chemotherapy. This study was conducted in accordance with the ethical standards of the Declaration of Helsinki of 1975.. https://doi.org/1 0.1007/s .

Tracking the dropout patients of neoadjuvant chemotherapy with locally advanced oral cavity cancer

tailieu.vn

neoadjuvant chemotherapy with locally advanced oral cavity cancer. Background: Patients with locally advanced oral cavity cancer sometimes stopped treatment after neoadjuvant chemotherapy. There are no guidelines of the management for these patients. Believing that chemotherapy would be effective and being afraid of the consequence of surgery were the main reasons of refusing surgery.. Locally advanced oral cavity cancer is highly morbid and life threatening.

Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2- negative breast cancer: A randomized pilot trial

tailieu.vn

Changes of CD4 + T cell among PBMCs after neoadjuvant endocrine therapy (NET) or neoadjuvant chemotherapy (NAC). Changes of ratio of Tregs to CD8 + T cells after NET or NAC. Changes of ratio of Tregs to NK cells after NET or NAC.. Neoadjuvant therapy-induced changes of circulating tumor-specific CTLs.. Changes of circulating tumor- specific CTLs after neoadjuvant endocrine therapy (NET). Changes of circulating tumor-specific CTLs after neoadjuvant chemotherapy (NAC)..

Efficacy of perioperative chemotherapy for synovial sarcoma: A retrospective analysis of a Nationwide database in Japan

tailieu.vn

Additionally, treatment with an ifosfamide-based regimen was reported to improve D- RFS (HR = 0.4, p . 8 cm of grade 2/3, or locally recurrent sarcoma/after in- adequate surgery of grade 2/3) indicated that a regi- men of 3 cycles of neoadjuvant chemotherapy was not superior to surgery alone in the included patients (5- year disease-free survival rates of 56 and 52% for the neoadjuvant chemotherapy and surgery-alone arms, respectively.

Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy

tailieu.vn

Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials. Breast Cancer Res Treat. Effect of body mass index- and actual weight-based neoadjuvant chemotherapy doses on pathologic complete response in operable breast Cancer. Clin Breast Cancer. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. chemotherapy among Chinese women with breast cancer.

Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer

tailieu.vn

Serum vitamin D levels affect pathologic complete response in patients undergoing neoadjuvant systemic therapy for operable breast Cancer.. Clin Breast Cancer. https://doi.org/10.1016/j.clbc . Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study. https://doi.org/10.1186/s x.. https://doi.org/10.1097/. https://doi.org/10.1590/S . doi.org X .

Dense hyperthermic intraperitoneal chemotherapy with cisplatin in patients with stage III serous epithelial ovarian cancer: A retrospective study

tailieu.vn

Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy. Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center. Long-term survival in patients with epithelial ovarian cancer following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil

tailieu.vn

They retrospectively examined 414 patients with meta- static colorectal cancer treated with capecitabine-based chemotherapy and reported that sarcopenia and/or muscle loss was associated with an increased risk of dose-limiting toxicities. They retro- spectively examined 41 patients with gastric cancer undergoing neoadjuvant chemotherapy and revealed that low SMM was the only factor significantly associated with severe diarrhea in univariate and multivariate ana- lyses.

Chapter 085. Neoplasms of the Lung (Part 14)

tailieu.vn

The main role of neoadjuvant chemotherapy is to control micrometastatic disease, and if this macroscopically evident disease is not sensitive to chemotherapy, it is unlikely that the microscopic disease will be controlled. Thus, surgical removal of the primary tumor after such chemotherapy is probably fruitless. Likewise, neoadjuvant chemotherapy generally should not be used to render inoperable disease operable.

The ideal approach for treatment of cT1N+ and cT2Nany esophageal cancer: A NCDB analysis

tailieu.vn

The introduction of both chemotherapy and radiation in the neoadjuvant and adjuvant settings has positively impacted survival in patients with locally advanced esophageal cancer. One major source of discussion is the use of neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone prior to surgery..

Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy

tailieu.vn

Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery. https://doi.org/10.1002/jso.24151.. Sato Y, Motoyama S, Wada Y, Wakita A, Kawakita Y, Nagaki Y, et al..